TECHBio-Techne
- Headquarters
- Minneapolis, MN
- CEO
- Kim Kelderman
- Next results
- around Feb 3, 2027
About Bio-Techne
10-K, Aug 24, 2026Bio-Techne and its subsidiaries, collectively doing business as Bio-Techne Corporation (“Bio-Techne”, “we”, “our”, “us” or the “Company”), develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. Our broad product portfolio and application expertise enables scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. Our products aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.
- Headquarters
- Minneapolis, MN
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- June 30
- Last results
- Aug 12, 2026
- Incorporated in
- MN
Permanent link, kept if the ticker changes: /c/sec:0000842023 (SEC's CIK).
Work on TECH in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/TECH/export.csv") into a cell.